Active · per the CBE, 31 October 2026

PHARMTHEEK

BE1021745738

Rechtspersoon Private limited company

PHARMTHEEK is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 1 April 2025.

Rue Ferrer 2, 1480 Tubize

Behind the company: YVES BOGNE TAKOUKAM, GERSONIE MOMO KENFACK.

Active for

1 year, 6 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMTHEEK from Tubize, company number BE1021745738, closed financial year 2025 with a result of € 21,535 after tax. For that financial year PHARMTHEEK recorded a gross margin of € 40,108 and equity of € 41,535. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 41,535

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 21,535

Profit after tax over the fiscal year.

Cash in the bank

€ 4,040

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 21,535.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt ≈ 11 years to go

€ 620,167

€ 56,926 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 1,537

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,154

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

What happened to PHARMTHEEK?

What happened at PHARMTHEEK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 21,535. filed late Source: NBB ↗
  • Start of the company according to the CBE. KBO

In short

Paid € 5,384 in corporate taxes since 2025.

Management

YVES BOGNE TAKOUKAM
GERSONIE MOMO KENFACK
PHARMTHEEK

Behind PHARMTHEEK are YVES BOGNE TAKOUKAM and GERSONIE MOMO KENFACK. It owns 100% of Pharmacie de Forest National itself.

Directors

According to the 2025 annual accounts

YVES BOGNE TAKOUKAM

Director

GERSONIE MOMO KENFACK

Director

Also active at: Pharmacie de Forest National, GOODHEAL

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Ferrer 2

1480 Tubize

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1021.745.738
VAT number
BE 1021.745.738
Registered office
Rue Ferrer 2, 1480 Tubize
Names & denominations
PHARMTHEEK
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 April 2025
Peppol
Active · Active since 12 Dec 2025
Activities · NACE

Activiteiten van holdings

Frequently asked questions

What does PHARMTHEEK do?
PHARMTHEEK is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 1 April 2025.
What is the address of PHARMTHEEK?
The registered office of PHARMTHEEK is located at Rue Ferrer 2, 1480 Tubize.
Is PHARMTHEEK still active?
Yes. According to the CBE (31 October 2026) PHARMTHEEK is active, legal situation “Normale toestand”, started on 1 April 2025.
Is PHARMTHEEK registered on Peppol?
Yes, PHARMTHEEK is registered on the Peppol network with ID 0208:1021745738.
What is the enterprise number of PHARMTHEEK?
The enterprise number of PHARMTHEEK is BE1021745738.
When was PHARMTHEEK founded?
PHARMTHEEK was founded on 1 April 2025.